Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations.
about
Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer.Evaluation of pretreatment serum interleukin-6 and tumour necrosis factor alpha as a potential biomarker for recurrence in patients with oral squamous cell carcinomaThe effect of the surgical margins on the outcome of patients with head and neck squamous cell carcinoma: single institution experience.The Prognostic Role of the Neutrophil-to-Lymphocyte Ratio in Oropharyngeal Carcinoma Treated with Chemoradiotherapy.The Effect of Head and Neck Radiotherapy on Blood Pressure and Orthostatic Hypotension in Patients With Head and Neck Tumors.Role of panendoscopy in identifying and managing risk of head and neck squamous cell carcinoma in routine follow-up: a retrospective clinical evaluation.
P2860
Management of squamous cell carcinoma of the head and neck: updated European treatment recommendations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of squamous cell ca ...... ean treatment recommendations.
@en
Management of squamous cell ca ...... ean treatment recommendations.
@nl
type
label
Management of squamous cell ca ...... ean treatment recommendations.
@en
Management of squamous cell ca ...... ean treatment recommendations.
@nl
prefLabel
Management of squamous cell ca ...... ean treatment recommendations.
@en
Management of squamous cell ca ...... ean treatment recommendations.
@nl
P2860
P356
P1476
Management of squamous cell ca ...... pean treatment recommendations
@en
P2093
Jordi Giralt
Monica Ramos
P2860
P304
P356
10.1586/ERA.10.6
P577
2010-03-01T00:00:00Z